Dr. John D. Sprandio, Sr., M.D.

Media Releases

Get to know Hematologist-Oncologist Dr. John D. Sprandio Sr., who serves patients in Pennsylvania.

Dr. Sprandio Sr. is a triple board-certified hematologist-oncologist whose special interests include head and neck cancer, lung cancer, leukemia, lymphoma, gastrointestinal malignancies, and clinical research. He serves as Chief of Medical Oncology and Hematology at Consultants in Medical Oncology and Hematology, where he operates out of the offices in Broomall, Newton Square, and Glen Mills, Pennsylvania.

In addition to being recognized as one of the region’s top community oncologists, Dr. Sprandio Sr. is a national leader in developing patient-centered care for cancer patients.  His program, Oncology Patient Centered Medical Home, provides both a philosophical base and a proven system for delivering high quality care to CMOH patients, as well as a model for community and hospital based practices nationally. 

His commitment to high quality cancer treatment, coordination of care, and excellent communication is the heart and soul of his practice and the OPCMH model. Dr. Sprandio Sr. writes and speaks frequently on OPCMH and healthcare issues to national audiences, as well as directs the CMOH practice.

“Oncologists know what to do. We need to move quickly to define, measure, and maximize the value of the Oncology Patient Centered Medical Home Model to become responsible, accountable, and able to achieve the goals of better cancer care, better health, and lower cost through improved delivery of care” he stated.

Among his other appointments, Dr. Sprandio Sr. is the Director of the Delaware County Memorial Hospital Regional Cancer Center, as well as has admitting privileges at Crozer-Chester Medical Center, Springfield Hospital, Taylor Hospital, and Bryn Mawr Hospital.

As an attending physician, some of the primary conditions that he treats include adenocarcinoma, blood disorders, breast cancer, leukemia, multiple myeloma, and metastatic breast cancer. He also utilizes chemotherapy as a primary treatment when necessary.

Academically, Dr. Sprandio Sr. graduated with his medical degree from the Temple University School of Medicine in 1980. He then went on to perform his internship and residency at Pennsylvania Hospital, after which he pursued a fellowship at Thomas Jefferson University Hospital.

Following his training, he attained board certification in medical oncology, hematology, and internal medicine through the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Among his professional affiliations, Dr. Sprandio Sr. is an active member of the Pennsylvania Heart Association and the Philadelphia County Medical Society.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Recommended Articles

• Treatment Options of Multiple Myeloma

  A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...

• John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society

  Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...

• 'Sophie the Brave' Fights Childhood T-Cell Lymphoma

  The story of 2-year-old Sophie Skiles and her arduous battle with T-cell lymphoma pulls at one’s heartstrings while also causing one to marvel at the faith of her Mom, Shelby.The public first learned of Sophie when a newscast about her was posted online October 20, 2017. (KLTB/abc) It soon made it...

• A Triathlon for Bloodwise

  Where would anyone be without friends? There have been many experiences where friends have been a bit of light in the dark. When 30-year-old Alexandra “Pixie” Flather from a town near Aylsham, England found out that her best friend was diagnosed with Leukemia, she decided to take action. At the...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...

• The Lymphoma Research Foundation Announces Partnership with the Annals of Lymphoma

  The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...